Michel Bouvier

Citado por

	Total	Desde 2019
Citas	44179	11744
Índice h	116	59
Índice i10	311	221

2200

1100

550

1650

1988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024133 188 311 410 361 444 400 469 522 510 549 519 561 684 699 1052 1269 1439 1509 1514 1447 1775 1795 1887 1723 1798 1813 1434 1492 1635 1750 1874 1745 2180 2145 1858 1933

Acceso público

Ver todo

157 artículos

10 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Stephane AngersDirector and Professor, Donnelly Centre, University of TorontoDirección de correo verificada de utoronto.ca
Robert J. LefkowitzJames B. Duke Professor of Medicine, Biochemistry, Chemistry; HHMI, Duke UniversityDirección de correo verificada de receptor-biol.duke.edu
Ali SalahpourProfessor, Department of Pharamcology and Toxicology, University of TorontoDirección de correo verificada de utoronto.ca
Terence HebertDepartment of Pharmacology and Therapeutics, McGill UniversityDirección de correo verificada de mcgill.ca
Stefano MarulloInserm, CNRS, Université de ParisDirección de correo verificada de inserm.fr
daniel bichetProfessor of Medicine, University of MontrealDirección de correo verificada de umontreal.ca
Stephane A. LaporteProfessor of Medicine, McGill UniversityDirección de correo verificada de mcgill.ca
Hiroyuki KobayashiIRIC, University of MontrealDirección de correo verificada de umontreal.ca
Jeffrey BenovicThomas Eakins Professor of Biochemistry and Molecular Biology, Thomas Jefferson UniversityDirección de correo verificada de jefferson.edu
Brian KobilkaStanford UniversityDirección de correo verificada de stanford.edu
Martin AudetUniversité de SherbrookeDirección de correo verificada de usherbrooke.ca
Graeme MilliganUniversity of GlasgowDirección de correo verificada de glasgow.ac.uk
Olivier LichtargeProfessor of Molecular and Human Genetics, Baylor College of MedicineDirección de correo verificada de bcm.edu
Sergi FerreNational Institute on Drug AbuseDirección de correo verificada de intra.nida.nih.gov
Amina S WoodsResearcher at the National Institute on Drug Abuse NIHDirección de correo verificada de intra.nida.nih.gov
Stephanie PontierCégep de l’OutaouaisDirección de correo verificada de cegepoutaouais.qc.ca
Francisco CiruelaIDIBELL-Universitat de BarcelonaDirección de correo verificada de ub.edu
Mohammed Akli AyoubKhalifa University - College of Medicine & Health Sciences, Department of Biological SciencesDirección de correo verificada de ku.ac.ae
Rithwik RamachandranUniversity of Western OntarioDirección de correo verificada de uwo.ca
Marta FilizolaDean and Professor at Icahn School of Medicine at Mount SinaiDirección de correo verificada de mssm.edu

Seguir

Michel Bouvier

Professor of Biochem. and Mol. Med., IRIC, Univ. de Montréal

Dirección de correo verificada de umontreal.ca - Página principal

G protein-coupled receptors GPCR Molecular Pharmacology BRET Cell Signaling


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Detection of β₂-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET) S Angers, A Salahpour, E Joly, S Hilairet, D Chelsky, M Dennis, M Bouvier Proceedings of the National Academy of Sciences 97 (7), 3684-3689, 2000	1053	2000
A peptide derived from a β2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation TE Hebert, S Moffett, JP Morello, TP Loisel, DG Bichet, C Barret, ... Journal of Biological Chemistry 271 (27), 16384-16392, 1996	1006	1996
Oligomerization of G-protein-coupled transmitter receptors M Bouvier Nature Reviews Neuroscience 2 (4), 274-286, 2001	873	2001
Palmitoylation of the human β2-adrenergic receptor: mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor BF O'dowd, M Hnatowich, MG Caron, RJ Lefkowitz, M Bouvier Journal of Biological Chemistry 264 (13), 7564-7569, 1989	798	1989
Roles of G‐protein‐coupled receptor dimerization: From ontogeny to signalling regulation S Terrillon, M Bouvier EMBO reports 5 (1), 30-34, 2004	791	2004
DIMERIZATION: An Emerging Concept for G Protein–Coupled Receptor Ontogeny and Function S Angers, A Salahpour, M Bouvier Annual review of pharmacology and toxicology 42 (1), 409-435, 2002	750	2002
Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants JP Morello, A Salahpour, A Laperrière, V Bernier, MF Arthus, M Lonergan, ... The Journal of clinical investigation 105 (7), 887-895, 2000	670	2000
β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors M Azzi, PG Charest, S Angers, G Rousseau, T Kohout, M Bouvier, ... Proceedings of the National Academy of Sciences 100 (20), 11406-11411, 2003	654	2003
Cross-talk between cellular signalling pathways suggested by phorbol-ester-induced adenylate cyclase phosphorylation T Yoshimasa, DR Sibley, M Bouvier, RJ Lefkowitz, MG Caron Nature 327 (6117), 67-70, 1987	633	1987
Quantitative assessment of β1-and β2-adrenergic receptor homo-and heterodimerization by bioluminescence resonance energy transfer JF Mercier, A Salahpour, S Angers, A Breit, M Bouvier Journal of Biological Chemistry 277 (47), 44925-44931, 2002	607	2002
Removal of phosphorylation sites from the β₂-adrenergic receptor delays onset of agonist-promoted desensitization M Bouvier, WP Hausdorff, AD Blasi, BF O'Dowd, BK Kobilka, MG Caron, ... Nature 333 (6171), 370-373, 1988	604	1988
Phosphorylation sites on two domains of the β2-adrenergic receptor are involved in distinct pathways of receptor desensitization WP Hausdorff, M Bouvier, BF O'dowd, GP Irons, MG Caron, RJ Lefkowitz Journal of Biological Chemistry 264 (21), 12657-12665, 1989	581	1989
GPCR-G protein-β-arrestin super-complex mediates sustained G protein signaling ARB Thomsen, B Plouffe, TJ Cahill, AK Shukla, JT Tarrasch, AM Dosey, ... Cell 166 (4), 907-919, 2016	573	2016
Probing the activation-promoted structural rearrangements in preassembled receptor–G protein complexes C Galés, JJJ Van Durm, S Schaak, S Pontier, Y Percherancier, M Audet, ... Nature structural & molecular biology 13 (9), 778-786, 2006	571	2006
Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer M Canals, D Marcellino, F Fanelli, F Ciruela, P De Benedetti, ... Journal of Biological Chemistry 278 (47), 46741-46749, 2003	567	2003
Emerging role of homo-and heterodimerization in G-protein-coupled receptor biosynthesis and maturation S Bulenger, S Marullo, M Bouvier Trends in pharmacological sciences 26 (3), 131-137, 2005	555	2005
Regulation of adenylyl cyclase-coupled beta-adrenergic receptors JL Benovic, M Bouvier, MG Caron, RJ Lefkowitz Annual review of cell biology 4 (1), 405-428, 1988	555	1988
Inverse agonist activity of beta-adrenergic antagonists. P Chidiac, TE Hebert, M Valiquette, M Dennis, M Bouvier Molecular pharmacology 45 (3), 490-499, 1994	521	1994
Real-time monitoring of receptor and G-protein interactions in living cells C Gales, RV Rebois, M Hogue, P Trieu, A Breit, TE Hébert, M Bouvier Nature methods 2 (3), 177-184, 2005	500	2005
Building a new conceptual framework for receptor heteromers S Ferré, R Baler, M Bouvier, MG Caron, LA Devi, T Durroux, K Fuxe, ... Nature chemical biology 5 (3), 131-134, 2009	484	2009

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores